Cencora, Inc. (LON: 0HF3)

London flag London · Delayed Price · Currency is GBP · Price in USD
228.71
+2.93 (1.30%)
Dec 20, 2024, 5:48 PM BST
13.58%
Market Cap 35.00B
Revenue (ttm) 219.32B
Net Income (ttm) 1.13B
Shares Out n/a
EPS (ttm) 5.62
PE Ratio 31.09
Forward PE n/a
Dividend n/a
Ex-Dividend Date Nov 15, 2024
Volume 51
Open 226.09
Previous Close 225.78
Day's Range 225.48 - 228.71
52-Week Range 150.19 - 240.15
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Jan 30, 2025

About Cencora

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company’s U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply ... [Read more]

Sector Healthcare
Founded 1871
Employees 46,000
Stock Exchange London Stock Exchange
Ticker Symbol 0HF3
Full Company Profile

Financial Performance

In 2024, Cencora's revenue was $293.96 billion, an increase of 12.12% compared to the previous year's $262.17 billion. Earnings were $1.51 billion, a decrease of -13.53%.

Financial numbers in USD Financial Statements

News

Cencora Closes $1.8 Billion Senior Notes Offering

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced the closing of its public offering of $500,000,000 aggregate principal amount of its 4.625% Senior Notes due December 15, ...

13 days ago - Business Wire

Cencora Launches Accelerate Pharmacy Solutions to Enhance Support for Hospital and Health System Customers

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, a global healthcare company, announced the launch of Accelerate Pharmacy Solutions, a unified portfolio of solutions designed to help hospital and health s...

17 days ago - Business Wire

Cencora: Competitive Advantages Defined

Cencora is a 'super cash cow' with high capital turnover and low margins, generating substantial free cash flow from its competitive advantages. COR's business model thrives on low-cost operations, en...

18 days ago - Seeking Alpha

Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it priced $500 million aggregate principal amount of its 4.625% Senior Notes due December 15, 2027 (the “2027 Notes”)...

20 days ago - Business Wire

Cencora to Host Inaugural Product Showcase

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, a global healthcare company, will host its inaugural Product Showcase, an event that will provide increased visibility into the company's portfolio of solu...

27 days ago - Business Wire

Cencora Acquires Retina Care Practice Network For $4.6 Billion, Boosts Dividend On Better Than Expected Q4 Earnings

On Wednesday, Cencora, Inc.'s COR fourth-quarter 2024 sales increased 14.7% to $79.1 billion, beating the consensus of $77.65 billion.

6 weeks ago - Benzinga

Cencora, Inc. (COR) Q4 2024 Earnings Call Transcript

Cencora, Inc. (NYSE:COR) Q4 2024 Earnings Call Transcript November 6, 2024 8:30 AM ET Company Participants Bennett Murphy - SVP, Head of IR Bob Mauch - President and CEO Laz Krikorian - SVP and CAO C...

6 weeks ago - Seeking Alpha

Cencora to buy Retina Consultants of America for $4.6 bln

Drug distributor Cencora said on Wednesday it would acquire Retina Consultants of America (RCA) for $4.6 billion in cash, gaining access to its network of eye specialists.

6 weeks ago - Reuters

Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 fourth quarter ended September 30, 2024, revenue increased 14.7 percent to $79.1 billion. Reve...

6 weeks ago - Business Wire

Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it has entered into a definitive agreement to acquire Retina Consultants of America (“RCA”), a leading management ser...

6 weeks ago - Business Wire

Cencora Expands Enterprise Leadership Team with Two Senior Appointments

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced the appointment of Francois Mandeville as Executive Vice President, Strategy and M&A, and Pawan Verma as Executive Vice Pr...

7 weeks ago - Business Wire

Dividend Aristocrats Of The Future - Part 3

This is the final group of 10 companies scheduled to reach dividend aristocrat status, sometime over the next five years. There are a variety of companies listed, some of whom may not be able to reach...

7 weeks ago - Seeking Alpha

Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Fourth Quarter of Fiscal 2024 on Wednesday, November 6, 2024, prior to the op...

2 months ago - Business Wire

Cencora Supports Pharmaceutical Supply Chain Education with Two New Programs for Health System Pharmacy Residents

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora (formerly AmerisourceBergen), a global healthcare company, announced its two latest pharmacy education initiatives that are designed to equip health system ...

3 months ago - Business Wire

Cencora Elects Frank Clyburn to Its Board of Directors

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has elected Frank Clyburn as a new independent director, effective October 1, 2024. With the e...

4 months ago - Business Wire

Intelliguard, Cencora Partner to Increase Compatibility of RFID-Tagged Medications, Medication Management Systems

SAN DIEGO & COLUMBUS, Ohio & DENVER--(BUSINESS WIRE)--Intelliguard, a fast-growing provider of medication management and data-intelligence solutions, announces an industry-transforming partnership wit...

4 months ago - Business Wire

Walgreens continues to shed stake in Cencora as it looks to bolster turnaround

Struggling drug-store chain Walgreens Boots Alliance Inc. has sold off shares of drug distributor Cencora Inc., handing the retailer some $1.1 billion in proceeds as it tries to carry out a turnaround...

5 months ago - Market Watch

Pharma giant Cencora is alerting millions about its data breach

Cencora has so far notified over a million people around the U.S. that their personal and protected health information was compromised in a data breach earlier this year, TechCrunch has found.

5 months ago - TechCrunch

Walgreens further reduces stake in Cencora

Walgreens Boots Alliance said on Thursday it has sold shares in drug distributor Cencora for proceeds of about $1.1 billion.

5 months ago - Reuters

Cencora Announces Common Share Repurchase From Walgreens Boots Alliance

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of ap...

5 months ago - Business Wire

Walgreens Boots Alliance Sells Shares of Cencora for Approximately $1.1 Billion of Proceeds

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that it has sold all of its remaining unencumbered shares of Cencora, Inc. (NYSE: COR) common stock pursu...

5 months ago - Business Wire

Cencora says additional data stolen in February cyberattack

U.S. drug distributor Cencora said on Wednesday additional data on patients, beyond what was initially identified, had been stolen in a cyberattack and data breach that happened in February.

5 months ago - Reuters

Cencora, Inc. (COR) Q3 2024 Earnings Call Transcript

Cencora, Inc. (NYSE:COR) Q3 2024 Earnings Conference Call July 31, 2024 8:30 AM ET Company Participants Bennett Murphy - Senior Vice President, Head of Investor Relations & Treasury Steve Collis - Ch...

5 months ago - Seeking Alpha

Cencora raises annual profit forecast on strong demand for specialty medicines

Cencora raised its annual profit forecast again on Wednesday, driven by strong demand for high-priced specialty medicines that treat complex diseases such as cancer.

5 months ago - Reuters

Cencora Reports Fiscal 2024 Third Quarter Results

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 third quarter ended June 30, 2024, revenue increased 10.9 percent year-over-year to $74.2 bill...

5 months ago - Business Wire